Nuvation Bio (NUVB)
US Market

Nuvation Bio (NUVB) Stock Price & Analysis


NUVB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.52 - $4.31
Previous Close$1.69
Average Volume (3M)534.59K
Market Cap
Enterprise Value-$271.17M
Total Cash (Recent Filing)$646.61M
Total Debt (Recent Filing)$3.97M
Price to Earnings (P/E)-3.5
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding218,803,722
10 Day Avg. Volume427,176
30 Day Avg. Volume534,586
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)0.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda2.30
Price Target Upside180.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Nuvation Bio’s price range in the past 12 months?
Nuvation Bio lowest stock price was $1.52 and its highest was $4.31 in the past 12 months.
    What is Nuvation Bio’s market cap?
    Currently, no data Available
    When is Nuvation Bio’s upcoming earnings report date?
    Nuvation Bio’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
      How were Nuvation Bio’s earnings last quarter?
      Nuvation Bio released its earnings results on May 04, 2023. The company reported -$0.1 earnings per share for the quarter, the consensus estimate of -$0.1 by $0.
        Is Nuvation Bio overvalued?
        According to Wall Street analysts Nuvation Bio’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Nuvation Bio pay dividends?
          Nuvation Bio does not currently pay dividends.
          What is Nuvation Bio’s EPS estimate?
          Nuvation Bio’s EPS estimate is -$0.11.
            How many shares outstanding does Nuvation Bio have?
            Nuvation Bio has 218,803,730 shares outstanding.
              What happened to Nuvation Bio’s price movement after its last earnings report?
              Nuvation Bio reported an EPS of -$0.1 in its last earnings report, expectations of -$0.1. Following the earnings report the stock price went up 3.086%.
                Which hedge fund is a major shareholder of Nuvation Bio?
                Among the largest hedge funds holding Nuvation Bio’s share is Omega Fund Management, LLC. It holds Nuvation Bio’s shares valued at 25M.


                  Nuvation Bio Stock Smart Score

                  The Nuvation Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Nuvation Bio

                  Panacea Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.


                  Top 5 ETFs holding NUVB

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  BMO MSCI Innovation Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold NUVB. The ETFs are listed according to market value of NUVB within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Viveve Medical
                  Acer Therapeutics
                  Daré Bioscience

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis